Biblio
Export 2536 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is S [Clear All Filters]
“The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 2, pp. 661-672, 2021.
, “Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.”, J Alzheimers Dis, vol. 52, no. 1, pp. 43-50, 2016.
, “Association of Gait Speed, Psychomotor Speed, and Dementia.”, J Alzheimers Dis, vol. 60, no. 2, pp. 585-592, 2017.
, “Association of Influenza Vaccination and Dementia Risk: A Meta-Analysis of Cohort Studies.”, J Alzheimers Dis, vol. 92, no. 2, pp. 667-678, 2023.
, “Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1069-1082, 2017.
, “Association of Low Systolic Blood Pressure with Postmortem Amyloid-β and Tau.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1755-1764, 2020.
, “Association of Low-Level Ozone with Cognitive Decline in Older Adults.”, J Alzheimers Dis, vol. 61, no. 1, pp. 67-78, 2018.
, “Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
, “The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1041-1052, 2018.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
, “Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-Analysis.”, J Alzheimers Dis, vol. 64, no. 3, pp. 875-887, 2018.
, “Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-Analysis.”, J Alzheimers Dis, vol. 64, no. 3, pp. 875-887, 2018.
, “Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1243-1248, 2020.
, “Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1243-1248, 2020.
, “Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1597-608, 2016.
, “Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus.”, J Alzheimers Dis, vol. 52, no. 1, pp. 161-9, 2016.
, “Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus.”, J Alzheimers Dis, vol. 52, no. 1, pp. 161-9, 2016.
, “Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.”, J Alzheimers Dis, vol. 63, no. 2, pp. 479-487, 2018.
, “Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.”, J Alzheimers Dis, vol. 63, no. 2, pp. 479-487, 2018.
, “Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.”, J Alzheimers Dis, vol. 63, no. 2, pp. 479-487, 2018.
, “Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.”, J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
,